Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

CORRECTION: Pihlajalinna publishes revised Half Year Financial Report 1 January-30 June 2016 (6 months)

Pihlajalinna Oyj
Posted on: 26 Aug 16

Pihlajalinna Plc     Half Year Financial Report     26 August 2016 at 8.00 a.m.

CORRECTION: Pihlajalinna publishes revised Half Year Financial Report 1 January - 30 June 2016 (6 months)

Pihlajalinna publishes revised Half Year Financial Report 1 Jan-30 Jun 2016 (6 months). There was an error concerning Groupincome taxes in Pihlajalinna's Half Year Financial Report 1 January-30 June 2016 published on 17 August 2016. The correction has a positive effect on the profit attributable to the owners of the parent.

Income taxes decreased and total comprehensive income improved by EUR 0.7 million in the Half Year Financial Report due to the correction. Earnings per share increased to 0.19 euros.

Pihlajalinna's outlook for 2016 remains unchanged. Pihlajalinna's consolidated revenue is expected to exceed EUR 400 million in 2016 and the adjusted EBIT margin is expected to improve compared to 2015. In the financial year 2015, the adjusted EBIT margin was 2.1 per cent.

Key changes due to the correction are presented in the table below. The revised Half Year Financial Report is attached to this release.

  4-6/2016
3 mths
4-6/2015
3 mths
1-6/2016
6 mths
1-6/2015
6 mths
2015
12 mths
INCOME STATEMENT, EUR million          
Income tax-0.50.1-1.60.1-0.1
Profit for the period2.6-0.65.30.01.2
Total comprehensive income for the period attributable:     
  To the owners of the parent2.0-0.73.9-0.30.5
      
BALANCE SHEET, EUR million          
Total assets (total statement of financial position)  217.3172.9185.1
Total equity  98.567.093.5
      
SHARE RELATED INFORMATION          
Earnings per share (EPS), EUR0.10-0.050.19-0.020.03
Equity per share, EUR  4.663.464.47
      
OTHER INFORMATION          
Return on capital employed (ROCE), %  7.13.63.4
Return on equity (ROE), %  6.81.22.3
Equity ratio, %  45.439.850.5
Gearing, %  33.936.625.2

Helsinki, 26 August 2016

Pihlajalinna Plc's Board of Directors

For further information please contact:

Aarne Aktan, CEO, tel. +358 40 342 4440
Niclas Köhler, CFO, tel. +358 40 342 4420

Distribution

Nasdaq Helsinki
Major media
investors.pihlajalinna.fi

Pihlajalinna in brief

Pihlajalinna is one of the leading private social and healthcare services providers in Finland. The Company provides social and healthcare services for households, companies, insurance companies and public sector entities in private clinics, health centres, dental clinics and hospitals around Finland. Pihlajalinna provides general practitioner and specialised care services, including emergency and on-call services, a wide range of surgical services, occupational healthcare and dental care services, in private clinics and hospitals operating under the Dextra brand. Under the Pihlajalinna brand the Company, in cooperation with the public sector, offers social and healthcare service provision models to public sector entities with the aim of providing high quality services for public pay healthcare customers.

Pihlajalinna H1 2016 ENG Revised


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Pihlajalinna Oyj via GlobeNewswire
HUG#2037220
GlobeNewswire
globenewswire.com

Last updated on: 27/08/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.